Effect of a rituximab-based regimen on the incidence of CNS relapse in patients with diffuse large B-cell lymphoma.

8098 Background: CNS relapse following initial treatment of DLBCL is an uncommon but fatal complication. The addition of rituximab improves the clinical outcome dramatically, but its influence on C...